Budesonide mixed with surfactant did not affect neurodevelopmental outcomes at 6 or 18 months corrected age in observational cohorts

BACKGROUND: The addition of budesonide to surfactant in very-low-birth-weight infants with less severe RDS decreased bronchopulmonary dysplasia (BPD) severity. Long-term neurodevelopmental follow-up was needed to monitor for systemic effects of budesonide. METHODS: Infants ≤1250 g who received intra...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Connie D., Kothe, T. Brett, Josephsen, Justin B., Sadiq, Farouk H., Burleyson, Nikki, Williams, Howard L., Hillman, Noah H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117121/
https://www.ncbi.nlm.nih.gov/pubmed/33986470
http://dx.doi.org/10.1038/s41372-021-01066-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117121/
https://www.ncbi.nlm.nih.gov/pubmed/33986470
http://dx.doi.org/10.1038/s41372-021-01066-x

Ejemplares similares